Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 2
2007 4
2008 3
2009 6
2010 11
2011 8
2012 9
2013 10
2014 13
2015 17
2016 14
2017 16
2018 20
2019 19
2020 17
2021 15
2022 8
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system.
Chiba Y, Kagabu M, Osakabe M, Ito R, Sato S, Takatori E, Kaido Y, Nagasawa T, Shoji T, Yanagawa N, Baba T. Chiba Y, et al. Among authors: baba t. Jpn J Clin Oncol. 2024 Apr 6;54(4):424-433. doi: 10.1093/jjco/hyad192. Jpn J Clin Oncol. 2024. PMID: 38251744
Prevalence of germline BRCA1/2 pathogenic variants in Japanese patients treated with castration-resistant prostate cancer and efficacy of CRPC treatment in real-world clinical practice.
Maekawa S, Takata R, Sekiguchi K, Kagabu M, Toyoshima M, Tamada S, Takahashi K, Ikarashi D, Matsuura T, Kato R, Kato Y, Kanehira M, Sugimura J, Abe T, Baba T, Obara W. Maekawa S, et al. Among authors: baba t. Jpn J Clin Oncol. 2024 Apr 6;54(4):489-497. doi: 10.1093/jjco/hyad185. Jpn J Clin Oncol. 2024. PMID: 38157885
Physical Properties of Ultrafine Bubbles Generated Using a Generator System.
Miyamoto S, Hirakawa T, Noguchi Y, Urushiyama D, Miyata K, Baba T, Yotsumoto F, Yasunaga S, Nakabayashi K, Hata K, Nakagawa W, Otsuka T, Nozawa Y, Furuhata I, Mikasa J. Miyamoto S, et al. Among authors: baba t. In Vivo. 2023 Nov-Dec;37(6):2555-2563. doi: 10.21873/invivo.13363. In Vivo. 2023. PMID: 37905634 Free PMC article.
A qualitative systematic review of the significance of adjuvant therapy in patients with low-risk endometrial cancer presenting positive peritoneal cytology: a relevant study to the guideline update for endometrial cancer by the Japan society of gynecologic oncology guideline committee.
Shigeta S, Konno Y, Terai Y, Morisada T, Tokunaga H, Baba T, Kobayashi Y, Nagase S. Shigeta S, et al. Among authors: baba t. Jpn J Clin Oncol. 2024 Feb 7;54(2):217-220. doi: 10.1093/jjco/hyad140. Jpn J Clin Oncol. 2024. PMID: 37823222
SLFN11 is a BRCA Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma.
Akashi H, Yachida N, Ueda H, Yamaguchi M, Yamawaki K, Tamura R, Suda K, Ishiguro T, Adachi S, Nagase Y, Ueda Y, Ueda M, Abiko K, Kagabu M, Baba T, Nakaoka H, Enomoto T, Murai J, Yoshihara K. Akashi H, et al. Among authors: baba t. Mol Cancer Ther. 2024 Jan 3;23(1):106-116. doi: 10.1158/1535-7163.MCT-23-0257. Mol Cancer Ther. 2024. PMID: 37717249
Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2020 and Annual Treatment Report for 2015.
Yoshino K, Kurita T, Takahashi F, Nagase S; Board members of the 2022 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology. Yoshino K, et al. J Obstet Gynaecol Res. 2023 Nov;49(11):2584-2592. doi: 10.1111/jog.15767. Epub 2023 Aug 21. J Obstet Gynaecol Res. 2023. PMID: 37602964
Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study.
Baba T, Koshiyama M, Kagabu M, Mikami Y, Minamiguchi S, Moritani S, Ishikawa M, Okamoto A, Terao Y, Nakanishi T, Katabuchi H, Tokunaga H, Satoh T, Konishi I, Yaegashi N. Baba T, et al. Int J Clin Oncol. 2023 Oct;28(10):1411-1420. doi: 10.1007/s10147-023-02393-z. Epub 2023 Aug 1. Int J Clin Oncol. 2023. PMID: 37526805
171 results